UFRF Royalty Report Sample Clauses

UFRF Royalty Report. Licensee: Agreement No.: Inventor: P#: P Period Covered: From: / /2 Through: / /2 Prepared By Date: Approved By: Date: If license covers several major product lines, please prepare a separate report for each line. Then combine all product lines into a summary report.
AutoNDA by SimpleDocs
UFRF Royalty Report. Company Name: If multiple license agreements are required to generate this product, indicate what percentage of the royalty is attributable to each agreement. UFRF Agreement No.: Percentage: UFRF Agreement No.: Percentage: Period Covered: From: / /2 Through: / /2 Prepared By: Date: Print Preparer Name: Preparer Email Address: ______________________Phone No.: _________________ Approved By: ____________________________________________ Date: ____________ (Requires Executive Officer Signature) Print Officer Name: If license covers multiple product lines, please prepare a separate spreadsheet for each product line, and a summary report for all products combined. The spreadsheet should include the following information: • Product Name • Country(ies) of Sales (List each country. If royalties vary by country, provide a breakdown of specified information for each country.) • Unit Sales
UFRF Royalty Report. Licensee Name: If multiple license agreements are required to generate this product, indicate what percentage of the royalty is attributable to each agreement. UFRF Agreement No.: Percentage: _________________________ UFRF Agreement No.: __________________ Percentage: ________________________ Period Covered: From / /20 Through / /20 Prepared By: Date: _____________ Print Preparer Name: Preparer Email Address: ____________________________Phone No.: _________________ Approved By: Date: (Requires Executive Officer Signature) Print Officer Name: If license covers multiple product lines, please prepare a separate spreadsheet for each product line, and a summary report for all products combined. The spreadsheet should include the following information: Product Name Country(ies) of Sales (List each country) Unit Sales Gross Sales Promotional Discounts (or other deductions) Net Sales Royalty Rates Total Royalty due this period Total Royalty paid last period Appendix E – Milestones Event Time [**] [**] [**] [**] [**] [**] Appendix F – Subsequently Added Intellectual Property Appendix GCertain Obligations Under [**] Policy
UFRF Royalty Report. Company Name: If multiple license agreements are required to generate this product, indicate what percentage of the royalty is attributable to each agreement. UFRF Agreement No.: Percentage: UFRF Agreement No.: Percentage: Period Covered: From: / /2 Through: / /2 Prepared By: Date: Print Preparer Name: Preparer Email Address: Phone No.: Approved By: Date: (Requires Executive Officer Signature) Print Officer Name: If license covers multiple product lines, please prepare a separate spreadsheet for each product line, and a summary report for all products combined. The spreadsheet should include the following information: • Product Name • Country(ies) of Sales (List each country. If royalties vary by country, provide a breakdown of specified information for each country.) • Unit Sales

Related to UFRF Royalty Report

  • Royalty Report The term “Royalty Report” shall have the meaning ascribed to such term as provided in Section 5.4.

  • Royalty Reports After the first commercial sale of a Licensed Product anywhere in the world, LICENSEE shall submit to UNIVERSITY quarterly royalty reports on or before each February 28, May 31, August 31 and November 30 of each year. Each royalty report shall cover LICENSEE’s (and each Affiliate’s and Sublicensee’s) most recently completed calendar quarter and shall show:

  • PROGRESS AND ROYALTY REPORTS 8.1. For the period beginning January 1st 2007, LICENSEE will submit to REGENTS a semi-annual progress report covering LICENSEE’s activities related to the development and testing of all LICENSED PRODUCTS, LICENSED SERVICES and LICENSED METHOD and the obtaining of necessary governmental approvals, if any, for marketing in the United States. These progress reports will be made for all development activities until the first SALE occurs in the United States.

  • Royalty Payment In partial consideration of the grant of rights to Schering by ICN under this Agreement, Schering shall pay ICN a royalty in the following amount:

  • Reports and Royalty Payments Within [* * *] days after the beginning of each Contract Quarter during the Royalty Term, Celgene shall deliver to Acceleron a report setting forth for the previous Contract Quarter the following information on a Licensed Product-by-Licensed Product and country-by-country basis in the Territory: (a) the gross sales and Net Sales of Licensed Product, (b) the number of units sold by Celgene, its Affiliates or Sublicensees, (c) the basis for any adjustments to the royalty payable for the sale of each Licensed Product, and (d) the royalty due hereunder for the sales of each Licensed Product (the “Royalty Report”). The total royalty due for the sale of Licensed Products during such Contract Quarter shall be remitted at the time such report is made. No such reports or royalty shall be due for any Licensed Product before the First Commercial Sale of such Licensed Product.

  • Royalty Statements The Licensees shall provide Shengqu with a statement within ten (10) Business Days of the end of each calendar month during the Term of this Agreement.

  • Royalty Payments (i) Royalties shall accrue when Licensed Products are invoiced, or if not invoiced, when delivered to a third party or Affiliate.

  • Reports; Payment of Royalty During the Term following the First Commercial Sale of a Product, Merck shall furnish to Ambrx a quarterly written report for the Calendar Quarter showing the Net Sales of all Royalty Products subject to royalty payments sold by Merck and its Related Parties in the Territory for use in the Field during the reporting period and the royalties payable under this Agreement. Reports shall be due on the [***] day following the close of each Calendar Quarter. Royalties shown to have accrued by each royalty report shall be due and payable on the date such royalty report is due. Merck shall keep complete and accurate records in sufficient detail to enable the royalties payable hereunder to be determined.

  • Know-How Royalty Notwithstanding the provisions of Section 5.4.1(a), in countries where the sale of Product by Merck or its Related Parties would not infringe a Valid Patent Claim, Merck shall pay royalty rates that shall be set at [***] of the applicable royalty rate determined according to Section 5.4.1(a). Such royalties shall be calculated after first calculating royalties under Section 5.4.1(a).

  • Royalty Reports and Accounting 15 6.1 "Royalty Reports; Records"................................................................... 15 6.2 "Payment Due Dates".......................................................................... 16 6.3 "Right to Audit"............................................................................. 16 6.4 "Confidentiality of Records"................................................................. 17

Time is Money Join Law Insider Premium to draft better contracts faster.